About Pasireotide Aspartate
Class: | Somatostatin analog
Use: | Treatment of Cushing's disease in adults who are not candidates for surgery or for whom surgery has failed
Adult dose: | Initial dose of 0.3 mg subcutaneously twice daily; may be adjusted based on clinical response and tolerability
Pediatric dose: | Safety and efficacy not established in pediatric populations
Side effects: | Diarrhea, nausea, abdominal pain, hyperglycemia, fatigue, injection site reactions
Contraindications: | Hypersensitivity to pas
Drug Class
Somatostatin analog
Uses & Indications
Treatment of Cushing's disease in adults who are not candidates for surgery or for whom surgery has failed
Storage Requirements
Store in the refrigerator (2°C to 8°C); do not freeze; may be kept at room temperature (up to 25°C) for up to 28 days after removal from the refrigerator
Manufacturer & Packaging
Manufacturer: Novartis Pharma AG, SWITZERLAND
Package Size
1ml Ampoule x 30 (6's Box x 5)
Price & Supplier
Price in UAE: AED 8401.50
Dosage Information
Adult Dose
Initial dose of 0.3 mg subcutaneously twice daily; may be adjusted based on clinical response and tolerability
Pediatric Dose
Safety and efficacy not established in pediatric populations
Side Effects
Diarrhea, nausea, abdominal pain, hyperglycemia, fatigue, injection site reactions
Contraindications & Precautions
Hypersensitivity to pasireotide or any component of the formulation; severe hepatic impairment
Important Warnings
Monitor for hyperglycemia; may cause gallbladder disease; caution in patients with diabetes or glucose intolerance; potential for QT prolongation; assess liver function prior to initiation and during treatment
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.